MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    The development of a multiplex allele specific PCR to improve the diagnostic yield of NGS in the GBA gene screening

    C. Panteghini, C. Reale, I. Colangelo, M. Suerz, R. Cilia, R. Eleopra, B. Garavaglia, F. Invernizzi (Milano, Italy)

    Objective: Our aim is to offer a complete and reliable diagnostic service excluding false negative. Background: Heterozygous variants in the GBA gene are the most…
  • 2023 International Congress

    Sensor-based digital measurement of gait and wrist pronation-supination in clinically-defined classes of Parkinson’s disease progression identified by unsupervised clustering

    D. Rodriguez Duque, J. Edgerton, L. Zhu, C. Kanzler, C. de Moor, S. Belachew, T. Dam, T. Liu, C. Shen, M. Yang, F. Nahab (Cambridge, USA)

    Objective: To determine how sensor-based measurement of motor performances relate to the heterogeneity of clinical progression in early Parkinson’s disease (PD). Background: Observed disease progression…
  • 2023 International Congress

    Neuropalliative communication curriculum: A review of the literature and needs assessment

    K. Block, A. Hiller, N. Leavell, S. Sorge (Portland, USA)

    Objective: We aim to improve neuropalliative education in neurology trainees by creating a reproducible didactic curriculum targeting specific communication techniques using case-based sensitive scenarios commonly…
  • 2023 International Congress

    Closed-loop gait improvement in Parkinson’s Disease

    P. Kirsch, M. Helbig, S. Baudrexel, C. Kell (Frankfurt am Main, Germany)

    Objective: The aim of this study was to measure gait parameters of patients with Parkinson’s Disease (PD) in everyday life situations and improve hypokinetic gait…
  • 2023 International Congress

    Risk and protective factors in Parkinson’s disease: a simultaneous and prospective study with linear and machine learning models

    MI. de Bartolo, A. Gialluisi, S. Costanzo, D. Belvisi, S. Falciglia, M. Ricci, A. Di Castelnuovo, T. Panzera, MB. Donati, G. Fabbrini, G. de Gaetano, A. Berardelli, L. Iacoviello (Pozzilli, Italy)

    Objective: To identify which risk/protective factors influenced most incident Parkinson's disease (PD) risk in a population of almost 24,000 Italian citizens, using both classical statistical…
  • 2023 International Congress

    Taking the driver’s seat on Parkinson’s care

    J. Benalcazar Silva (Melbourne, Australia)

    Objective: To provide insight into the unique service and support offered by the multidisciplinary health team to address the challenges and dilemmas faced by people…
  • 2023 International Congress

    Effect of intensive Game-based neurorehabilitation (GBNR) on gait, balance and quality of life (QOL) in Parkinson’s patients: A prospective randomized control study

    R. Savaj, P. Vengurlekar, C. Sankhla, S. Patel (Mumbai, India)

    Objective: To assess changes in the gait, balance and QOL in PD patients subjected to intensive GBNR in comparison with conventional Neurorehabilitation (NR) therapy using…
  • 2023 International Congress

    Effect of Best Practice Advisory on the administration of contraindicated medications to hospitalized patients with Parkinson’s disease and related disorders

    N. Chunga, K. Amodeo, M. Braun, B. Valdovinos, I. Richard (Rochester, USA)

    Objective: To determine if a best practice advisory (BPA) reduced the orders and administration of contraindicated dopamine blocking agents (DBA) to hospitalized patients with Parkinson’s…
  • 2023 International Congress

    Patients activation in people with Parkinson disease and its relation to personal factors

    B. Naamneh Abuelhija, M. Kafri, M. Kestenbaum, S. Giveon, G. Yogev-Seligmann (Haifa, Israel)

    Objective: To identify individual factors associated with patient activation among people with Parkinson’s disease (PD). Background: The concept of patient activation captures subjective aspects of…
  • 2023 International Congress

    A vicious cycle of karyopherin abnormalities in synucleinopathies

    D. Sharipov, E. Bereczki, R. Killick, T. Hortobagyi, C. Troakes, D. Aarsland, F. Hirth (London, United Kingdom)

    Objective: This study aims to investigate the role of karyopherin abnormalities in the onset and progression of synucleinopathies. Background: Despite differences in clinical manifestations, Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 384
  • 385
  • 386
  • 387
  • 388
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley